IQVIQVIA
IQVIA is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. 10-K, Item 1
- Headquarters
- Durham, NC
- CEO
- Ari Bousbib
- Next results
- around Feb 4, 2027
What the debt is made of, and when it is due
balance sheet of Sep 30, 2026The debt note's own lines, 2025-12-31
| Line, as the company names it | Kind | Rate | Fixed or floating | Amount |
|---|---|---|---|---|
| Senior Secured Credit Facilities | Total of the lines | – | not stated | $5.2B |
| Foreign currency denominated debt | – | – | not stated | $3.0B |
| Senior Notes Due 20306.250 (USD, Senior Notes) | Notes and bonds | 6.25% | not stated | $2.0B |
From the debt note in the 10-K's XBRL (0001628280-26-008322), as the company tags it: by issue, by year, by currency or by kind. Lines from two ways of cutting the same debt can overlap, so they are not added up. Fixed or floating is read from the line's own name only; "not stated" when it says neither.
Left: the debt lines on the balance sheet (XBRL). Right: the principal due each year, from the debt note's maturity schedule; it can differ a little from the balance sheet, which shows the debt net of discounts and fees. Leases are not counted.
When IQV has to repay the principal of its long-term debt, from the debt note of the 10-Q filed Oct 27, 2026 (balance sheet of Sep 30, 2026). Fiscal years are counted from that date.
| When | Principal due | Share | |
|---|---|---|---|
| Next 12 months FY2027 | $1.8B | 11% | |
| Year 2 FY2028 | $2.5B | 16% | |
| Year 3 FY2029 | $2.4B | 15% | |
| Year 4 FY2030 | $2.5B | 15% | |
| Year 5 FY2031 | $6.9B | 43% |
Principal only: interest, leases and commercial paper are not in this schedule. Hover a row for its XBRL line. Open the filing ↗
Work on IQV in a spreadsheet:
Excel workbook (a sheet per section, ten years by column, charts, links to the filings) ·
CSV.
For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/IQV/export.csv") into a cell.